Harrow, Inc. Due to Related Parties, Current
Harrow, Inc. (HROW) had Due to Related Parties, Current of $27.54 thousand as of 2011-09-30, per its 10-Q filed 2012-02-23.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2012-02-23
- 2011-09-30: Due to Related Parties, Current $27.54K.
- 2010-12-31: Due to Related Parties, Current $0.00.
| Period end | Due to Related Parties, Current |
|---|---|
| 2011-09-30 | $27.54K 10-Q · filed 2012-02-23 |
| 2010-12-31 | $0.00 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |